Skip to main content
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
24.04
-0.95 (-3.80%)
At close: Apr 19, 2024, 3:38 PM
23.53
-0.51 (-2.12%)
After-hours: Apr 19, 2024, 7:05 PM EDT

vTv Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for vTv Therapeutics.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for VTVT.

Recommendation Trends

Rating Oct '22Nov '22Dec '22Jan '23Feb '23Mar '23
Strong Buy 000000
Buy 222220
Hold 000000
Sell 000000
Strong Sell 000000
Total 222220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Vernon Bernardino
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Reiterates
$240
 Strong Buy Reiterates $240 +898.34% Mar 7, 2023
Carl Byrnes
Northland Capital Markets
 Northland Capital Markets
Buy
Maintains
$60 → $80
 Buy Maintains $60 → $80 +232.78% Aug 17, 2022
Charles Duncan
Cantor Fitzgerald
 Cantor Fitzgerald
Buy
Initiates
$200
 Buy Initiates $200 +731.95% Feb 18, 2022
Vernon Bernardino
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Reiterates
$200 → $240
 Strong Buy Reiterates $200 → $240 +898.34% Feb 10, 2020
Vernon Bernardino
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Initiates
$200
 Strong Buy Initiates $200 +731.95% May 30, 2019
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.34
from -9.71
EPS Next Year
n/a
from -0.34
Year 201920202021202220232024
Revenue
2.76M6.41M4.01M2.02M--
Revenue Growth
-77.77%132.05%-37.56%-49.61%--
EPS
-23.60-7.20-8.29-9.98-9.71-0.34
EPS Growth
------
No. Analysts -----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2024
High n/a
Avg n/a
Low n/a

Revenue Growth

Revenue Growth 2024
High -
Avg -
Low -

EPS Forecast

EPS 2024
High -0.35
Avg -0.34
Low -0.32

EPS Growth

EPS Growth 2024
High -
Avg -
Low -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.